“Evaluating multiple clinically relevant timepoints,
from apheresis through post-infusion timepoints,
will be invaluable for identifying the most
desirable and functional CAR T cell populations
and may provide insight into potential
approaches to optimize CAR T cell therapies for
the future.”
